Abstract: Understanding the mechanisms underlying protein receptor function and their roles in cellular processes is crucial for advancing biological discovery. In this study, we employ a ...

Discover Enlicitide, a new daily pill for genetic high cholesterol (HeFH). A recent trial shows it lowers bad LDL cholesterol ...

Atherosclerotic cardiovascular disease is a leading cause of morbidity and mortality globally. Elevated levels of serum LDL-C (low-density lipoprotein cholesterol) represent a significant risk factor ...

Scribe Therapeutics highlights data underpinning its comprehensive strategy targeting key lipid drivers of ASCVD at AHA Scientific Sessions 2025 ...

The drug enlicitide reduced cholesterol for adults with high levels due to an inherited disorder and may also work for a broader population.

A cholesterol-lowering regimen that combines PCSK9 inhibitor alirocumab with statin therapy safely reduced low-density lipoprotein cholesterol (LDL-C) levels by more than 50% in adults early after ...

WASHINGTON -- Daily treatment with the novel drug saroglitazar significantly reduced liver fat in women with metabolic ...

The drug works by preventing PCSK9 from interacting with LDL receptors, allowing more receptors to remove LDL cholesterol from the blood. Merck plans to share data from this trial and other studies ...

1 School of Pharmacy, Hubei University of Science and Technology, Xianning, China 2 Hubei Key Laboratory of Diabetes and Angiopathy, Hubei University of Science and Technology, Xianning, China The low ...